Broken record time ... the science appears to have amazing potential, in so many areas, and within reputable entities and their study and analysis.

Hopefully management can eventually leverage this notable and novel science/safety profile with financial opportunities for further development in North America, or abroad (Asia, Africa, Middle East, S.America).

Or, find a suitable BP buyer that recongnizes the ABL and epigenetics platform value and potential within their current portfolio, or for their future pipeline. 

I am also intersted in the thoughts of the science folks on the board, regarding this publication!